Laboratorio de Virología Molecular, Facultad de Ciencias, Centro de Investigaciones Nucleares, Igua 4225, 11400 Montevideo, Uruguay.
Virol J. 2009 Dec 4;6:215. doi: 10.1186/1743-422X-6-215.
A sudden emergence of Influenza A Virus (IAV) infections with a new pandemic H1N1 IAV is taking place since April of 2009. In order to gain insight into the mode of evolution of these new H1N1 strains, we performed a Bayesian coalescent Markov chain Monte Carlo (MCMC) analysis of full-length neuraminidase (NA) gene sequences of 62 H1N1 IAV strains (isolated from March 30th to by July 28th, 2009).
The results of these studies revealed that the expansion population growth model was the best to fit the sequence data. A mean of evolutionary change of 7.84 x 10(-3) nucleotide substitutions per site per year (s/s/y) was obtained for the NA gene. A significant contribution of first codon position to this mean rate was observed. Maximum clade credibility trees revealed a rapid diversification of NA genes in different genetic lineages, all of them containing Oseltamivir-resistant viruses of very recent emergence. Mapping of naturally occurring amino acid substitutions in the NA protein from 2009 H1N1 IAV circulating in 62 different patients revealed that substitutions are distributed all around the surface of the molecule, leaving the hydrophobic core and the catalytic site essentially untouched.
High evolutionary rates and fast population growth have contributed to the initial transmission dynamics of 2009 H1N1 IAV. Naturally occurring substitutions are preferentially located at the protein surface and do not interfere with the NA active site. Antigenic regions relevant for vaccine development can differ from previous vaccine strains and vary among patients.
自 2009 年 4 月以来,甲型流感病毒(IAV)感染出现了一种新的大流行 H1N1 IAV。为了深入了解这些新的 H1N1 毒株的进化模式,我们对 62 株 H1N1 IAV (于 2009 年 3 月 30 日至 7 月 28 日分离)的全长神经氨酸酶(NA)基因序列进行了贝叶斯合并马尔可夫链蒙特卡罗(MCMC)分析。
这些研究结果表明,扩展种群增长模型最适合拟合序列数据。NA 基因的平均进化变化率为每年每核苷酸替代 7.84 x 10(-3)(s/s/y)。第一个密码子位置对这一平均值有显著贡献。最大枝可信度树揭示了不同遗传谱系中 NA 基因的快速多样化,所有这些谱系都含有最近出现的奥司他韦耐药病毒。对来自 62 位不同患者的 2009 年 H1N1 IAV 循环中的 NA 蛋白中自然发生的氨基酸替代进行映射,揭示了替代物分布在分子表面,而疏水核心和催化部位基本未受影响。
高进化率和快速的种群增长促成了 2009 年 H1N1 IAV 的初始传播动态。自然发生的替代物优先位于蛋白质表面,不干扰 NA 活性部位。与疫苗开发相关的抗原区域可能与以前的疫苗株不同,并且在患者之间也有所不同。